middle.news
PolyNovo Unveils H1 FY26 Growth Momentum with NovoSorb Innovation
9:36am on Wednesday 25th of February, 2026 AEDT
•
Healthcare
Read Story
PolyNovo Unveils H1 FY26 Growth Momentum with NovoSorb Innovation
9:36am on Wednesday 25th of February, 2026 AEDT
Key Points
H1 FY26 investor call webcast now available
Continued revenue growth and profitability highlighted
NovoSorb polymer technology driving advanced wound care products
FDA-cleared NovoSorb MTX gaining rapid surgeon adoption
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
POLYNOVO (ASX:PNV)
OPEN ARTICLE